Kabra Drugs Ltd — Results, 30-05-2025: Result

Kabra Drugs Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total income of Rs. 64.02 lakhs for the quarter, mainly from other income, with no revenue from operations. Employee benefit expenses rose to Rs. 25.13 lakhs, while other expenses showed a negative figure due to reclassification adjustments. The company posted a net profit of Rs. 39.36 lakhs this quarter, compared to losses in the prior periods. The paid-up equity share capital increased significantly to Rs. 2,370.79 lakhs from Rs. 438.86 lakhs. Cash and cash equivalents grew substantially to Rs. 2,129.93 lakhs. There were no deviations in the utilization of Rs. 21.8 Cr raised through preferential allotment, which is meant for working capital, acquisitions, and growth initiatives. The audit was completed with an unmodified opinion.